research use only
Cat.No.S2924
| Related Targets | PI3K Akt mTOR ATM/ATR DNA-PK AMPK PDPK1 PTEN PP2A PDK |
|---|---|
| Other GSK-3 Inhibitors | CHIR-99021 (Laduviglusib) SB216763 CHIR-98014 TWS119 GSK-3 Inhibitor IX (BIO) LY2090314 Tideglusib SB415286 AR-A014418 1-Azakenpaullone |
|
In vitro |
DMSO
: 100 mg/mL
(199.28 mM)
Ethanol : 100 mg/mL Water : 1.5 mg/mL The solubility data above are all experimental results (not literature values). |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
Read more about Laduviglusib (CHIR-99021) Hydrochloride solubility in DMSO or water
| Information | Laduviglusib (CHIR-99021) Hydrochloride is a potent and specific GSK-3β inhibitor. It affects Wnt/β-catenin and PI3K/AKT signaling by inhibiting GSK-3β to induce β-catenin accumulation, effectively promoting stem cell differentiation, cellular reprogramming, and proliferation while inhibiting apoptosis and fibrosis. |
|---|---|
|
Read more about Laduviglusib (CHIR-99021) Hydrochloride IC50 for cell-based and cell-free assays |
|
| Primary Applications and Mechanism of Action | |
Read more about Laduviglusib (CHIR-99021) Hydrochloride Mechanism of Action
| Molecular Weight | 501.8 | Formula | C22H18Cl2N8.HCl |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 1797989-42-4 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | CT99021 HCl | Smiles | CC1=CN=C(N1)C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)Cl)NCCNC4=NC=C(C=C4)C#N.Cl | ||
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
Question 1:
How about the half-life of this compound? If it is necessary for daily treatment when it is used in long-term experiment?
Answer:
If the duration is more than 72h, please change the culture medium each day to add it in.
Question 2:
What is the difference between S2924 and S1263? Which one is better for differentiation?
Answer:
S1263 is the free base format of Chir-99021, while S2924 is its HCl salt format. They have the same biological activity but are slightly different in solubility.